ImaginAb

ImaginAb is an emerging immune-oncology imaging company developing a pipeline of new products that give doctors unprecedented insight into patient health, enabling better patient selection and monitoring of immuno-oncology therapies and other drugs.Leveraging the specificity of monoclonal antibodies, ImaginAb designs and engineers small, highly targeted proteins called minibodies to image important molecular targets via standard Positron Emission Tomography (PET).Our imaging tools help doctors answer critical clinical questions, improve care pathways and ultimately help patients live longer, healthier lives.